Consensus Guidelines for the Use of Palivizumab in Infants and Young Children with Congenital Heart Disease (JSPCCS 2019)

Hiroyuki Yamagishi; Kotaro Oyama; Masaru Miura; Hiroshi Ono; Utako Yokoyama; Satoshi Kusuda; Hiroyuki Tsutsumi; Fukiko Ichida; Naokata Sumitomo

doi:10.24509/jpccs.0401G1

Consensus Guidelines for the Use of Palivizumab in Infants and Young Children with Congenital Heart Disease (JSPCCS 2019)

Hiroyuki Yamagishi¹，Kotaro Oyama²，Masaru Miura³，Hiroshi Ono⁴，Utako Yokoyama⁵，Satoshi Kusuda⁶，Hiroyuki Tsutsumi⁷，Fukiko Ichida⁸，Naokata Sumitomo⁹Hiroyuki Yamagishi¹, Kotaro Oyama², Masaru Miura³, Hiroshi Ono⁴, Utako Yokoyama⁵, Satoshi Kusuda⁶, Hiroyuki Tsutsumi⁷, Fukiko Ichida⁸, Naokata Sumitomo⁹

¹ Keio University

² Iwate Medical University

³ Tokyo Metropolitan Children’s Medical Center

⁴ National Center for Child Health and Development

⁵ Tokyo Medical University

⁶ Kyorin University

⁷ Hokkaido Saiseikai Nishi Otaru Hospital Midori no Sato

⁸ International University of Health and Welfare

⁹ Saitama Medical University International Medical Center

発行日：2020年3月1日Published: March 1, 2020

Journal of Pediatric Cardiology and Cardiac Surgery

GuidelineGuideline

Consensus Guidelines for the Use of Palivizumab in Infants and Young Children with Congenital Heart Disease (JSPCCS 2019)